High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$577K
$577,173
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ATRA
S
Atara Biotherapeutics, Inc.
Grant-Huerta Yanina
• Officer • Chief Accounting Officer
Sell to Cover
2026-03-02
$10,691x4
|
||||||
| ATRA |
Atara Biotherapeutics, Inc.
|
Officer • Chief Accounting Officer
Sell to Cover
|
2026-03-02 | $10,691x4 | S | Form 4 |
| ATRA |
Atara Biotherapeutics, Inc.
|
CEO
Sell to Cover
|
2026-03-02 | $15,237x4 | S | Form 4 |
|
ATRA
S
Atara Biotherapeutics, Inc.
Panacea Innovation Ltd
• 10% Owner
Discretionary Sell
2026-01-12
$489,019
|
||||||
| ATRA |
Atara Biotherapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2026-01-12 | $489,019 | S | Form 4 |
|
ATRA
S
Atara Biotherapeutics, Inc.
Grant-Huerta Yanina
• Officer • Chief Accounting Officer
Sell to Cover
2025-11-17
$23,788x3
|
||||||
| ATRA |
Atara Biotherapeutics, Inc.
|
Officer • Chief Accounting Officer
Sell to Cover
|
2025-11-17 | $23,788x3 | S | Form 4 |
| ATRA |
Atara Biotherapeutics, Inc.
|
CEO
Sell to Cover
|
2025-11-17 | $38,437x2 | S | Form 4 |